Cost-effectiveness analysis of encorafenib and binimetinib combination as first-line treatment for metastatic or unresectable BRAF V600-mutated metastatic melanoma in Russia von Avxentyev, N. A., Makarova, Yu. V.

Volltext

Modeling the impact of using trastuzumab deruxtecan in patients with breast cancer on reducing cancer mortality in Russia von Avxentyev, N. A., Makarova, Yu. V., Makarov, A. S.

Volltext

Long-term analysis of сanagliflozin budget impact in adult patients with type 2 diabetes mellitus and diabetic nephropathy in the Russian Federation von Avxentyev, N. A., Makarova, Yu. V.

Volltext

Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literat... von Avxentyev, N. A., Andreyashkina, I. I., Artamonova, E. V., Bolotina, L. V., Kovalenko, E. I., Sisigina, N. N.

Volltext

Estimating long-term overall survival with olaparib as maintenance therapy in patients with newly diagnosed advanced ovarian cancer with BRCA mutations von Avxentyev, N. A., Khokhlova, S. V., Frolov, M. Yu, Makarov, A. S.

Volltext

Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer von Avxentyev, N. A., Lubennikova, E. V., Frolov, M. Yu

Volltext

Pharmacoeconomic analysis of therapy with brentuximab vedotin, nivolumab and pembrolizumab in patients with relapsed Hodgkin’s lymphoma von Avxentyev, N. A., Pazuhina, E. M., Tumyan, G. S., Zeynalova, P. A.

Volltext

Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia von Avxentyev, N. A., Frolov, M. Yu, Makarov, A. S.

Volltext

Pharmacoeconomic Analysis Of Everolimus Immunosupressive Therapy After Renal Transplantation von Avxentyeva, M, Avxentyev, NA, Frolov, M, Derkach, EV

Volltext

PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA von Avxentyev, N. A., Frolov, M. Yu

Volltext

Costs Of Overactive Bladder Symptoms Treatment With Solifenacin von Avxentyeva, M, Gerasimova, K, Khachatryan, GR, Frolov, M, Avxentyev, NA, Pyadushkina, E

Volltext

METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY von Avxentyev, N. A., Derkach, E. V., Pyadushkina, E. A., Ter-Ovanesov, M. D.

Volltext

EE402 Social and Economic Burden of Breast Cancer in Russia von Avxentyev, NA, Makarova, Y

Volltext

EE676 Impact of Using Innovative Antineoplastic Drugs on Cancer Mortality in Russia von Avxentyev, NA, Sisigina, N, Frolov, M, Makarov, A

Volltext

EE404 Forecast of Social and Economic Burden of HIV-Infection in Russia in Different Scenarios of Anti-HIV Policy up to 2035 von Avxentyev, NA, Avxentyeva, M, Makarov, A, Makarova, Y

Volltext

EE539 Social and Economic Burden of HIV in Russia von Avxentyev, NA, Avxentyeva, M, Makarov, A, Makarova, Y

Volltext

How could we improve the national projects in health and demography after coronavirus pandemic? von Avxentyev, N. A., Nazarov, V. S., Sisigina, N. N.

Volltext

Pharmacoeconomic Analysis of Enzalutamide and Abiraterone for Treatment of Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer von Avxentyev, NA, Frolov, M

Volltext

PCN137 - Pharmacoeconomic Analysis of Enzalutamide and Abiraterone for Treatment of Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer von Avxentyev, NA, Frolov, M

Volltext

Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer von N. A. Avxentyev, A. S. Makarov, M. Yu. Frolov

Volltext